Table 1. Summary of included studies.
| Author | Mean age (year) | N of OCDa | N of male OCDa | N of HCa | N of male NHCa | Diagnostic tool | Duration of illness (year) | Psychiatric comorbidity | Medication |
Y-BOCSb |
Magnetic field strength (tesla) | Segmentation | MRS sequence | Single- vs multi- voxel | Types of measure | TE (ms) | TR (ms) | NAA | Cre | Cho | mI | Glx | VOI location | VOI size (ml) | Results | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Obsession | Compulsion | |||||||||||||||||||||||||
| Atmaca et al.51 | 28.1 | 18 | 6 | 18 | 6 | DSM-IV | 5.5 | No | No | 17.2 | NA | NA | 1.5 | Undone | NA | Single | Cre ratio | 15.6 | 2000 | ○ | ○ | ○ | × | × | bl.hippocampus | 4.7 | NAA↓ |
| Bartha et al.50 | 34.9 | 13 | 7 | 13 | 7 | DSM-IV | NA | No | No | 25.9 | 11.6 | 14.3 | 1.5 | Undone | NA | Single | Absolute | 20 | 1500 | ○ | ○ | ○ | ○ | ○ | lt.corpus striatum | 4.5 | NAA↓ |
| Beédard et al.43 | 40.54 | 13 | 4 | 12 | 4 | DSM-IV | 12.77 | No | Medicated | 26.5 | 12.92 | 13.62 | 1.5 | Undone | PROBE | Single | Cre ratio | 102 | 3100 | ○ | × | ○ | ○ | ○ | rt.OFA | 8 | NS |
| ○ | × | ○ | ○ | ○ | lt.OFA | 8 | NS | ||||||||||||||||||||
| ○ | × | ○ | ○ | ○ | rt.MTL | 8 | NS | ||||||||||||||||||||
| ○ | × | ○ | ○ | ○ | lt.MTL | 8 | NS | ||||||||||||||||||||
| ○ | × | ○ | ○ | ○ | rt.thalamus | 9 | NS | ||||||||||||||||||||
| ○ | × | ○ | ○ | ○ | lt.thalamus | 9 | NS | ||||||||||||||||||||
| ○ | × | ○ | ○ | ○ | ACC | 9.6 | NS | ||||||||||||||||||||
| Besiroglu et al.42 | 32.1 | 30 | 12 | 15 | 6 | DSM-IV | 6.35 | No | No | 24.15 | 13.1 | 11.05 | 1.5 | Undone | PRESS | Single | Absolute Cre ratio | 135 | 1500 | ○ | ○ | ○ | × | × | rt.ACC | 8 | NAA↓ |
| ○ | ○ | ○ | × | × | rt.AHC | 4.096 | NAA↓ | ||||||||||||||||||||
| Ebert et al.34 | 27 | 12 | 8 | 6 | 5 | DSM-IV | 11 | No | No | 28 | NA | NA | 2 | Undone | PRESS | Single | Cre ratio | 30 | 1500 | ○ | × | ○ | ○ | ○ | ACC | 8 | NAA↓ |
| ○ | × | ○ | ○ | ○ | rt.striatum | 8 | NAA↓ | ||||||||||||||||||||
| ○ | × | ○ | ○ | ○ | rt.PL | 8 | NS | ||||||||||||||||||||
| Fan et al.24 | 25.62 | 21 | 12 | 19 | 13 | DSM-IV | 4.45 | No | No | 22.52 | NA | NA | 1.5 | Undone | PRESS | Single | Cre ratio | 35 | 1500 | ○ | × | ○ | ○ | × | MPFC | 8 | NAA↓ |
| Jang et al.22 | 27.77 | 13 | 8 | 13 | 8 | DSM-IV | 7.23 | Two: depression | No | 30.23 | 15.31 | 14.92 | 1.5 | Done | PRESS | Multi | Cre ratio | 272 | 2000 | ○ | × | × | × | × | ACC | 1.125 | NAA↓ |
| ○ | × | × | × | × | FWM | 1.125 | NAA↓ | ||||||||||||||||||||
| ○ | × | × | × | × | Prefrontal cortex | 1.125 | NAA↓ | ||||||||||||||||||||
| ○ | × | × | × | × | PC | 1.125 | NS | ||||||||||||||||||||
| ○ | × | × | × | × | PWM | 1.125 | NS | ||||||||||||||||||||
| ○ | × | × | × | × | Posterior cingulate | 1.125 | NS | ||||||||||||||||||||
| Kitamura et al.26 | 22.7 | 12 | 3 | 32 | 10 | DSM-IV | 6.3 | No | Medicated | 20.4 | NA | NA | 3 | Undone | PRESS | Single | Cre ratio | 24 | 6000 | ○ | × | ○ | × | × | ACC | 3 | NS |
| ○ | × | ○ | × | × | lt.basal ganglia | 6.75 | NS | ||||||||||||||||||||
| ○ | × | ○ | × | × | lt.thalamus | 3.375 | NS | ||||||||||||||||||||
| ○ | × | ○ | × | × | lt.FWM | 3.375 | NS | ||||||||||||||||||||
| ○ | × | ○ | × | × | lt.PWM | 3.375 | NS | ||||||||||||||||||||
| Mirza et al.38 | 10.31 | 27 | 13 | 18 | NA | DSM-IV | 2.63 | No | No | 26.8 | NA | NA | 1.5 | Undone | NA | Single | Absolute | 272 | 2300 | ○ | ○ | ○ | × | × | lt.thalamus | 0.8 | NS |
| ○ | ○ | ○ | × | × | rt.thalamus | 0.8 | NS | ||||||||||||||||||||
| Mohamed et al.28 | 36.7 | 10 | 4 | 10 | 4 | DSM-IV | 23.5 | No | Medicated | 14.3 | NA | NA | 1.5 | Undone | NA | Single | Cre ratio | 280 | 2650 | ○ | × | ○ | × | × | lt.thalamus | 1.1 | NS |
| ○ | × | ○ | × | × | rt.thalamus | 1.1 | NAA↓ | ||||||||||||||||||||
| ○ | × | ○ | × | × | lt.basal ganglia | 1.1 | NS | ||||||||||||||||||||
| ○ | × | ○ | × | × | rt. basal ganglia | 1.1 | NS | ||||||||||||||||||||
| Ohara et al.35 | 24.5 | 12 | 10 | 12 | 10 | DSM-IV | 5.6 | No | Medicated | 29.5 | NA | NA | 1.5 | Undone | PROBE | Single | Cre ratio | 40 | 1500 | ○ | × | ○ | × | × | lt.lenticular nucleus | 8 | NS |
| ○ | × | ○ | × | × | rt.lenticular nucleus | 8 | NS | ||||||||||||||||||||
| Rosenberg et al.23 | 11.39 | 20 | 9 | 14 | 5 | DSM-IV | 3.87 | Two: anxiety | No | 25.8 | NA | NA | 1.5 | Undone | PRESS | Single | Absolute | 272 | 2300 | ○ | ○ | ○ | ○ | ○ | ACC | 3 | NS |
| Rosenberg et al. 37 | 11.19 | 11 | 4 | 11 | 4 | DSM-IV | 2.56 | Yes: anxiety | No | 26.55 | NA | NA | 1.5 | Undone | PRESS | Single | Absolute | 272 | 2300 | ○ | ○ | ○ | × | × | lt.medial thalamus | NA | NS |
| ○ | ○ | ○ | × | × | rt.medial thalamus | NA | NS | ||||||||||||||||||||
| ○ | ○ | ○ | × | × | lt.lateral thalamus | NA | NS | ||||||||||||||||||||
| ○ | ○ | ○ | × | × | rt.lateral thalamus | NA | NS | ||||||||||||||||||||
| Rosenberg et al.36 | 11 | 11 | 4 | 11 | 4 | K-SADS-PLc | 1.2 | Yes: anxiety | No | 30.36 | 15.27 | 15.09 | 1.5 | Undone | PRESS | Single | Absolute | 272 | 2300 | ○ | ○ | ○ | ○ | ○ | lt.caudate | 0.7 | NS |
| ○ | ○ | ○ | ○ | ○ | Occipital gray matter | 8 | NS | ||||||||||||||||||||
| Scherk et al.40 | NA | 17 | NA | 16 | NA | DSM-IV | NA | No | Medicated | NA | NA | NA | 1.5 | Undone | NA | Single | Cre ratio | 30 | 1500 | ○ | × | ○ | ○ | ○ | DLPFC | 3.5 | NS |
| ○ | × | ○ | ○ | ○ | PMFC | 3.6 | NS | ||||||||||||||||||||
| ○ | × | ○ | ○ | ○ | Putamen | 3.3 | NS | ||||||||||||||||||||
| Starck et al.41 | 32.6 | 9 | 6 | 15 | 11 | DSM-IV | 19.4 | Yes: depression | Medicated | 22.9 | 11.9 | 11 | 1.5 | Undone | PRESS | Single | Absolute | 30 | 2000 | ○ | ○ | ○ | ○ | ○ | rt.caudate nucleus | 1.5 | NA |
| ○ | ○ | ○ | ○ | ○ | Anterior cingulate gyrus | 3.6 | NA | ||||||||||||||||||||
| ○ | ○ | ○ | ○ | ○ | OC | 4 | NA | ||||||||||||||||||||
| Sumitani et al.27 | 29.99 | 20 | 13 | 26 | 10 | DSM-IV | NA | NA | Medicated | 23.79 | NA | NA | 1.5 | Done | STEAM | Single | Absolute | 18 | 5000 | ○ | ○ | ○ | × | × | ACC | 4.335 | NAA↓ |
| ○ | ○ | ○ | × | × | lt.basal ganglia | 4.335 | NS | ||||||||||||||||||||
| ○ | ○ | ○ | × | × | lt.FL | 4.335 | NS | ||||||||||||||||||||
| Whiteside et al.39 | 41.2 | 15 | 9 | 15 | 9 | DSM-IV | 23.09 | Yes: depression | Medicated | 24.13 | 11.73 | 12.4 | 1.5 | Undone | PROBE | Single | Cre ratio | 35 | 2000 | ○ | × | ○ | ○ | ○ | lt.head of caudate | 4 | NS |
| ○ | × | ○ | ○ | ○ | rt.head of caudate | 4 | NS | ||||||||||||||||||||
| ○ | × | ○ | ○ | ○ | lt.OFWM | 4 | NS | ||||||||||||||||||||
| ○ | × | ○ | ○ | ○ | rt.OFWM | 4 | NAA↓ | ||||||||||||||||||||
| Yucel et al.31 | 34.4 | 20 | 10 | 26 | 13 | DSM-IV | 13.4 | NA | No/stable | 19.55 | 9.35 | 10.2 | 3 | Done | PRESS | Single | Absolute | 30 | 3000 | ○ | ○ | ○ | ○ | ○ | rt.dACC | 6.5 | NS |
| ○ | ○ | ○ | ○ | ○ | rt.rACC | 6.5 | NS | ||||||||||||||||||||
| ○ | ○ | ○ | ○ | ○ | lt.dACC | 6.5 | NS | ||||||||||||||||||||
| ○ | ○ | ○ | ○ | ○ | lt.rACC | 6.5 | NS | ||||||||||||||||||||
Abbreviations: ACC, anterior cingulate cortex; AHC, amygdala hippocampus complex; bl., bilateral; Cre,creatine; dAC, dorsal anterior cingulate; dACC, dorsal anterior cingulate cortex; DLPFC, dorsolateral prefrontal cortex; FL, frontal lobe; FWM, frontal white matter; HC, healthy control; lt., left; MPFC, medial prefrontal cortex; MRS, magnetic resonance spectroscopy; MTL, medial temporal lobe; NA, not applicable; NAA, N-acetylaspartate; NHC, non-healthy control; NS, nonsignificant; OC, occipital cortex; OCD, obsessive-compulsive disorder; OFA, orbitofrontal area; OFWM, orbitofrontal white matter; PC, parietal cortex; PMFC, posterior frontal cortex; PWM, parietal white matter; PL, parietal lobe; rACC, rostal anterior cingulate cortex; rt., right; TE, echo time; TR, repetition time; VOI, volume of interest.
Number.
Yale–Brown Obsessive Compulsive Scale.
The schedule for affective disorders abd schizophrenia for school-age children—present and lifetime versions.